Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2012, v. 10, n. 1, p. 71
- By:
- Publication type:
- Article
Works matching IS 1359-4117 AND VI 10 AND IP 1 AND DT 2012
Results: 8
1
2
Nedaplatin and irinotecan for patients with recurrent small cell lung cancer.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2012, v. 10, n. 1, p. 65
- By:
- Publication type:
- Article
3
Inhibition of cell proliferation and induction of apoptosis by CDDO-Me in pancreatic cancer cells is ROS-dependent.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2012, v. 10, n. 1, p. 51
- By:
- Publication type:
- Article
4
D-Pinitol attenuates 7, 12 dimethylbenz [a] anthracene induced hazards through modulating protein bound carbohydrates, adenosine triphosphatases and lysosomal enzymes during experimental mammary carcinogenesis.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2012, v. 10, n. 1, p. 39
- By:
- Publication type:
- Article
5
Intra-arterial bevacizumab with blood brain barrier disruption in a glioblastoma xenograft model.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2012, v. 10, n. 1, p. 31
- By:
- Publication type:
- Article
6
Are fragile sites "Hot-Spots": A causative factor in tumor biology.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2012, v. 10, n. 1, p. 19
- By:
- Publication type:
- Article
7
Nox4 inhibition enhances the cytotoxicity of cisplatin in human renal cancer cells.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2012, v. 10, n. 1, p. 9
- By:
- Publication type:
- Article
8
Anticancer agent xanthohumol inhibits IL-2 induced signaling pathways involved in T cell proliferation.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2012, v. 10, n. 1, p. 1
- By:
- Publication type:
- Article